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Abstract
Background: In brain-injured patients intracranial pressure (ICP) is monitored invasively by a ventricular or
intraparenchymal transducer. The procedure requires specific expertise and exposes the patient to complications
such as malposition, hemorrhage or infection. As inner-ear fluid compartments are connected to the cerebrospinal
fluid space, ICP changes elicit subtle changes in the physiology of the inner ear. Notably, we previously demonstrated
that the phase of cochlear microphonic potential (CM) generated by sound stimuli rotates with ICP. The aim of our
study was to validate the monitoring of CM as a noninvasive method to follow ICP.
Methods: Non-invasive measure of CM-phase was compared to ICP recorded invasively in a prospective series of
patients with acute brain injury managed in a neuro-intensive care unit. The study focused on patients with varying
ICP and normal middle-ear function.
Results: In the 24 patients with less than 4 days of endotracheal ventilation and whose ICP fluctuated (50-hour data),
we demonstrated close correlation between CM-phase rotation and ICP (average 1.26 degrees/mmHg). As a binary
classifier, CM phase changes of 7–10 degrees signaled 7.5-mmHg ICP increases with a sensitivity of 83% and 19%
fallout.
Conclusion: Reference methods to measure ICP require the surgical placement of a pressure transducer. Noninvasive
CM-based monitoring of ICP might be beneficial to early management of brain-injured patients with initially preserved
consciousness and to the diagnosis of neurological conditions, whenever invasive monitoring cannot be performed.
Trial registration: ClinicalTrials.gov NCT01685476, registered on 30 August 2012.
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Background
In brain-injured patients, intracranial pressure (ICP) is
monitored to manage cerebral perfusion pressure and
prevent secondary lesions [1, 2]. The gold standard for
monitoring ICP is provided by the surgical placement of a
ventricular or intraparenchymal transducer [3–5]. These
invasive procedures require specific expertise and expose
to malposition, hemorrhage and infection. Therefore, they
are restricted to critical situations in which cerebral perfu-
sion pressure monitoring is mandatory. Conversely, in
intermediate situations such as the diagnosis of migraine,
headache, glaucoma and initial management of moderate
traumatic brain injury, non-invasive methods that would
reliably measure ICP are in great demand.
Cochlear sensory-cell responses to sound stimuli may
address this challenge. Their detection is routinely applied
in screening of neonatal hearing, by paramedics after min-
imal training. The sensitivity of cochlear sensory-cell re-
sponses to ICP changes results from a balance between
cerebrospinal and intralabyrinthine fluid pressures [6–8],
such that by modifying the ossicular chain stiffness, ICP
variations rotate the phase of cochlear responses. Nonin-
vasive monitoring using either pasted skin electrodes or a
microphone in the external acoustic meatus allows ICP
follow up [6]. Here, we monitored cochlear microphonics
(CM) [9], a sufficiently robust response that circumvents
the negative influence of noisy environments and of age-
related presbycusis. Concomitant invasive ICP and non-
invasive CM recordings were compared over several hours
in brain-injured patients, so as to determine whether one
can establish a limit in CM-phase change that would sig-
nal a potentially dangerous ICP trend.
Methods
Experimental design
The objective of the research was to confront noninvasive
ICP monitoring using CM with invasive ICP monitoring
in patients with acute brain injury managed in a neuro-
intensive care unit (NICU). During the one-year enrol-
ment period, 53 consecutive patients were enrolled in this
prospective, observational study. The inclusion criterion
was the possibility of organizing a monitoring session
without disturbing the NICU schedule, and prior to this
session, of obtaining informed consent from an authorized
person. In view of the collected raw data, all patients mea-
sured more than 4 days after NICU referral were excluded
from further analysis. The main reason was the lack of suf-
ficient ICP fluctuations in these patients, as the intended
search for correlation between CM and ICP is valid only if
the independent variable, ICP, exhibits enough variability.
Patients
The patients had been referred to the NICU for head
trauma, including brain hemorrhage, tumors, stroke or
meningitis. They were intubated, mechanically ventilated
and sedated with sufentanil plus midazolam or remifen-
tanil using target-controlled infusions [10].
CM and ICP recordings
The CM is a voltage that results from sound-induced cur-
rents flowing at the frequency of a sound stimulus
through the transduction ion channels of auditory sensory
cells. Otoacoustic emissions, similarly sensitive to ICP
changes [6, 11], are sounds reemitted by the same cells,
also as a result of transduction. CM is detected noninva-
sively between a gold-coated electrode (tip-trode™, active)
inserted in the external acoustic meatus and skin
electrodes pasted on the forehead (passive and ground).
The CM-eliciting stimulus is a tone sent by a calibrated
earphone (see Additional file 1).
The chosen stimulus frequency, near 1000 Hz, is the
frequency most sensitive to ICP changes [7, 9]. The volt-
age between the electrodes is amplified (×100,000) and
digitally converted for on-line spectral analysis. It is
made of the CM, frequency-locked to the stimulus, and
of components associated with cortical and muscular
activity, with a broadband frequency spectrum that falls
mainly below 500 Hz. Possible electric artifacts from the
NICU are generally made up of lines at integer multiples
of the mains frequency, distinct from the stimulus fre-
quency. With a sound stimulus of 80–85 dB sound
pressure level (SPL) applied for 10–20 s, the CM is at
least 10 dB above background electric noise, which
guarantees a valid phase measurement, stable as long as
ICP does not change. CM was preferred to otoacoustic
emissions for which instrumentally generated artefacts
occur when the level of sound-eliciting stimuli exceeds
75 dB SPL [11]. At lower levels of stimulus, otoacoustic
emissions would barely emerge from acoustic noise in
the NICU.
The whole process was automatic, driven by a hand-
held, battery-driven audiological system (Elios™, Echodia).
The only action undertaken by the NICU nurses was posi-
tioning of the electrodes. The fastest rate of CM sampling
was one point every 10–20 s in the NICU environment.
Here, for monitoring sessions scheduled to exceed 60
minutes, one CM data point was collected every 5
minutes. For monitoring sessions of 30–60 minutes,
the sampling rate increased to 1/minute and for even
shorter sessions, to 3/minute. In parallel, ICP was con-
tinuously monitored through an intraparenchymal probe
(Codman™ microsensor, Johnson & Johnson). Data col-
lection was stopped when nursing procedures required
the monitoring equipment to be disconnected. Acciden-
tal earplug-electrode dislocation, which occurred once,
led to invalid data, which was identified and discarded
offline.
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Middle-ear assessment
The CM technique detects a phase rotation due to the
change in stiffness of the ossicular chain induced by ICP.
If middle-ear mechanics are modified by a confounding
factor, e.g., a poorly ventilated or fluid-filled middle-ear
cavity, the CM phase may undergo an additional rotation
and the sensitivity of the CM-phase-to-ICP relationship
may change. After video-otoscopic examination of the
tympanic membrane, the tip of a tympanometer (Titan™,
Interacoustics) was inserted. By sweeping the air pressure
in the sealed ear canal, tympanometry determines whether
the tympanic membrane optimally transmits sound pres-
sure to the cochlea at atmospheric pressure. Insufficient
middle-ear ventilation or middle-ear effusion is thus read-
ily identified. As these two conditions are known to be
induced by long-lasting intubation and the resulting
auditory-tube dysfunction [12, 13], a subgroup of patients
received tympanometry every day for 10 days while intu-
bated (n = 6) and 6 days after discharge (n = 5), to docu-
ment the time-course of possible middle-ear disruption
(see Additional file 2).
Ethics
The protocol was approved by the local Ethics Commit-
tee and National ANSM Agency, and registered in the
Clinical trials register under the number NTC01685476
(protocol NIMI-NICU: Non Invasive Monitoring of the
Intracranial Pressure- Neurointensive Care Unit). In-
formed consent was initially given by an authorized
person, pending the patient's own consent, recovery
permitting.
Statistical analysis
Pearson's correlation between ICP and CM phase
changes were analyzed for each monitoring session, with
the correlation coefficient (R), the determination coeffi-
cient (R2) and the 95% confidence interval for the correl-
ation coefficient as outcomes. The slope of the linear
regression line relating CM-phase change to ICP change
was computed for each ear. Its correlation with other
factors, namely age and severity indexes, was studied.
Receiver-operating characteristics (ROC) were plotted,
representing sensitivity against 1 - specificity of the CM-
based binary classifier, with each point corresponding to
a gradually increasing discrimination threshold, defined
as the CM-phase-change boundary between pass and
refer diagnoses. Several ROC analyses were performed,
using two different gold standards for ICP increase
(against which CM phase increases were tested), 5 mm
and 7.5 mmHg; and two different gold standards for ICP
decrease (against which CM phase increases were
tested), 5 mm and 7.5 mmHg. The optimal CM-phase-
change limit was determined either according to the
Youden index, or from the best trade-off between the
risk of false negatives that dismiss genuinely threatening
ICP increases, and of false positives that might induce
an over-reaction to harmless ICP changes.
Results
Status of patients and outcome of their monitoring
Although all 53 patients who were tested had valid
monitoring signals from the intraparenchymal ICP
transducer and the CM electrodes (at least in one ear),
only the data from the 24 patients who had not been
intubated for more than 4 days when tested were fur-
ther analyzed. These patients were aged between 19
and 76 years (mean 43, SD 16; 59% male). Seventeen
patients had been referred with head trauma, three with
brain hemorrhage and four with a tumor, stroke or
meningitis. At referral, which occurred on average 3.9 h
(SD 4.4) after symptom onset, the mean Glasgow score
was 5.3 (SD 3.4), mean ICP was 18.9 mmHg (SD 11.4),
with ICP over 20 mmHg in 11 patients. Severity was
54.8 (SD 14.3) on the Simplified Acute Physiology
Score (SAPS-II score) and 8.2 (SD 2.2) on the Sequen-
tial Organ Failure Assessment score (SOFA score).
When their CM was monitored, all of these 24 patients
had normal middle-ear function as assessed by tympano-
metry. Conversely, none of the excluded patients (n = 29)
who had been endotracheally ventilated for more than 4
days when tested, had a normal tympanometry (negative
pressure in the middle ear cavity in 8 cases, effusion in 21
cases). In the subgroup of patients who received everyday
tympanometry, it was possible to check that middle-ear
negative pressure, then effusion, developed from the fifth
day post intubation (Additional file 2). Monitoring ses-
sions ran from a few minutes to more than 4 h (mean 123
minutes, SD 85 minutes; total ICP monitoring data 50 h).
Intermittent sound stimulations required by the CM
technique did not influence the management of sedation.
Figure 2 depicts representative examples of the collected
ICP and CM raw data. Figure S3 in (Additional file 3)
completes the picture by showing the remaining set of data.
Events, defined by changes in ICP of 3 mmHg or
more, on two consecutive ICP data points at least, were
observed in all patients. Overall, 38 events were regis-
tered, 18 ICP increases and 20 decreases. The amplitude
of ICP changes was broadly distributed, below 20 mmHg
in 29 events (Fig. 1a). A typical monitoring session in-
cluded events lasting less than 40 minutes in 75% of cases
(Fig. 1b), and periods of over 60 minutes with stable ICP,
during which it was possible to verify whether CM phase
was also stable.
A normal tympanogram guarantees normal sound
conduction with a linear relationship between the CM
phase and ICP [9], as the stiffness of the ossicular chain
primarily depends on intralabyrinthine pressure that closely
follows ICP [8]. This was confirmed by a correlation
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coefficient between 0.55 and 0.90, significantly different
from 0 in 21 out of 24 patients (Fig. 1c). The inspection of
individual plots (Fig. 2a-i; also see Additional file 3) con-
firms that the CM phase captured isolated events of a few
minutes or over an hour (Fig. 2a-c) and provided a fine
tracking of slow upward (Fig. 2d) or downward drifts of
ICP (Fig. 2e), and of complex patterns of fluctuations
(Fig. 2f-h).
Conversely, the CM phase usually appeared stable when
ICP did not change (Fig. 2a, f, i; also see Additional file 3:
Figure S3I, J, L). These situations, inadequately described
by the linear-correlation technique, will be quantified sub-
sequently within this paper. In three patients, the correl-
ation was not statistically significant (Additional file 3:
Figure S3M-O). In two patients (Additional file 3: Figure
S3M, O), premature interruption of data collection by a
nursing procedure led to scarce ICP data points and too
narrow a range of ICP variation to identify correlation,
despite the close match between the CM phase and ICP.
Pooled changes in the CM phase were linearly correlated
with ICP changes (R = +0.66; p < 0.0001). Individual slopes
of the CM-phase-to-ICP linear regression displayed some
variability (Fig. 3a). Slopes were comparable whether ICP
increased beyond 30 mmHg (six cases) or not, which sug-
gests that the method can still detect ICP increases even
when initial ICP is already abnormal. The average slope
was 1.26 degrees of CM phase shift per mmHg increase in
ICP (SD 0.74).
Age was weakly correlated with the quality of CM moni-
toring in relation to ICP (Fig. 3b, with borderline signifi-
cance (R = -0.43; p = 0.045) possibly unduly influenced by
two outliers. The slope of the CM-phase-to-ICP changes
in degrees/mmHg displayed no significant correlation
with age (R = 0.27; p = 0.23). Severity indexes did not
explain the variability of outcomes (p = 0.67 and 0.31 for
SAPS-II and SOFA, respectively).
Ability of CM phase to trigger alarms as a binary classifier
A possible application of the CM-phase monitoring was
assessed with the help of receiver operating characteris-
tics (ROC), namely the ability to warn of ICP changes of
+5 and -5 mmHg. For the +5 mmHg criterion (Fig. 3c;
18 events), the optimal cutoff for CM-phase shift was
10°, with sensitivity of 64% and specificity of 91%,
according to Youden's index (respective 95% confidence
intervals (44–84) and (89–94)). The area under the
curve was 0.83. Sensitivity rose to 73% with little loss in
specificity (83%) with a CM-phase shift of 7° as the
cutoff.
If the alarming ICP increase was set at +7.5 mmHg in-
stead of 5 mmHg, the ROC had an area under the curve
of 0.84, with an optimal cutoff at 7° for the CM-phase
shift, implying sensitivity of 83% (i.e., a 19% improvement
relative to the +5 mmHg criterion), and specificity
remaining good at 81%. In the mirror situation of a 5
mmHg decrease in ICP (Fig. 3d; 20 events), the area under
Fig. 1 Characteristics of intracranial pressure (ICP) events and their tracking by cochlear microphonic potential (CM). a Size of ICP events in
mmHg. b Duration of ICP events in minutes. c Pearson correlation coefficients (R) describing the CM-phase-to-ICP linear relationship, vertically
aligned for every individual ear (stars), with the 95% confidence interval for each of them (bars)
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the ROC curve was 0.93, with an optimal CM-phase shift
cutoff of -5°, ensuring sensitivity of 88% and specificity of
81% according to Youden's index (respective 95% confi-
dence intervals (73–100) and (78–84)).
Discussion
Ability to detect ICP trends
The close similarity between the time courses of CM-
phase and invasive ICP suggests promising clinical appli-
cations. This similarity is attested by highly significant
linear correlation over several hours, between the CM-
phase and ICP in 21 of the 24 patients at an average rate
of 1.26 degree/mmHg. To circumvent the inability of the
CM method to provide absolute ICP without the help of
initial invasive calibration, CM-phase changes were used
as a binary classifier for tracking ICP changes (5– 7.5
mm Hg) over periods of 3–4 h, in patients with no
middle-ear impairment.
The performance of the resulting classification com-
pared favorably to those of other methods that targeted
similar ICP changes [14], with sensitivity and specificity
of around 80% for a dataset comprising 50 h of continu-
ous recordings. In other words, a possibly alarming
trend of ICP, defined as an increase of 5 mmHg over
several minutes, was signaled by a concomitant increase
in the CM-phase of 7° with 27% false negatives. In the
context of objective screening for intracranial hyperten-
sion, false negatives are a more serious issue than false
alarms, as in the absence of a monitoring tool all pa-
tients would have to be considered at risk.
A conservative use of ROC analysis thus chooses a more
stringent CM-phase limit than that of Youden's index.
False negatives decreased to 17% when an ICP increase of
7.5 mmHg was targeted. Conversely, when ICP variation
remained less than 5 mmHg, the rate of false alarms that
a drifting CM phase would trigger was less than 20%. The
tracking of ICP decreases performed even slightly better.
An important target of the present method, i.e., patients
with a steady ICP increase, 5 mmHg then 7.5 and more
after the accident, would thus be spotted early and effi-
ciently enough to be directed to an appropriate emergency
ward with little risk of undue alarm.
Fig. 2 Examples of individual time courses of ICP (red, mmHg) and CM phase (blue, degrees). Vertical range: 20 mmHg for ICP in all diagrams;
adjusted according to the CM-phase-to-ICP slope, for CM phase (also see Fig. 3a). In every panel labeled from a-i, patient numbers (#n, upper right
corners) match those in Fig. 1c, left column. Dashed lines: intervals of time during which data collection was interrupted by a nursing procedure
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Limitations of the monitoring method
Abnormal transmission of sound through the middle ear
must be ruled out as it may influence the CM phase in
an unpredictable manner. Tympanometry, which can be
performed by paramedics after minimal training (and
might be implemented in CM measuring devices), is rec-
ommended in the category of patients with head trauma
with fractures, to rule out bilateral middle-ear involve-
ment. In patients intubated for fewer than 5 days, middle-
ear status remains normal, ensuring large CM-to-ICP cor-
relations. In patients who stay longer in NICU, middle-ear
effusion develops in relation to intubation and uncon-
sciousness [12]. In traumatic brain injury, noninvasive ICP
monitoring should no longer be needed after 4 days, as
intracranial hypertension generally develops in the first 48
h after the trauma.
The CM monitoring procedure conducted with an
extratympanic electrode is harmless, complying with se-
curity requirements on exposure to loud sounds, which
tolerate an 8-h, 80-dB (in Europe) or 85-dB (in the USA)
daily exposure. With the chosen sampling rate, suitable
for detecting slow changes in ICP, patients were exposed
to sound for about 20 s every 5 minutes and showed no
reaction to sound presentation.
CM measurements have been routinely used for
decades in audiology [15]. The present protocol is suffi-
ciently user-friendly to be implemented by nurses whose
tasks are to position an earplug in the external auditory
meatus and two skin electrodes on the forehead of the
patients. CM monitoring is automatic and inadvertent
electrode removal is detected by the software. The cost
of use is limited to that of disposable electrodes. There
are similar hand-held and battery-powered versions of
audiological systems that are used outside of medical fa-
cilities. Here, CM was successfully monitored in the
noisy environment of NICU, suggesting that a CM-
detecting device could be used aboard an emergency
vehicle or even, at the site of an accident.
Comparison to other non-invasive methods
Most non-invasive methods require initial invasive
calibration [16] except transcranial Doppler ultrasound
measurement of blood flows in the intra and extracranial
segments of the ophthalmic artery. The estimate of abso-
lute ICP given by this method is the pressure applied on
the eyeball, such that blood flow in both segments of the
ophthalmic artery is equalized [17, 18]. For ICPs below
40 mmHg, the reported standard deviation of the error
is small, 6.2 mmHg. Yet, the procedure is too intrusive
for continuous monitoring and requires advanced tech-
nical skills. The method of Kashif et al. [14] estimates ICP
every minute, with little bias and a satisfactory standard
deviation of the error (7.6 mmHg) for ICPs up to 100
mmHg. However, it requires a model simulating brain
properties to be fed by minimally invasive clinical data, ar-
terial blood pressure and cerebral blood flow derived from
transcranial ultrasound.
Invasive ICP measurements are not exempt from
technical problems. The baseline drift of ICP micro-
transducers reaches up to 7.3 mmHg so that the
Fig. 3 Statistical analysis of cochlear microphonic potential (CM) monitoring outcomes. a linear fits of individual CM-phase to intracranial pressure
(ICP) relationships. b Pearson R coefficients against age. c-d Receiver operating characteristic plots of true positive vs fallout of binary classifications
based upon a 5-mmHg increase in ICP (c) and a 5-mmHg decrease in ICP (d)
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standard deviation of the error may vary from 3.4 to 8.5
mmHg [19]. External ventricular drainage may be
obstructed or disabled by intraventricular hemorrhage
or ventricular compression by brain edema. In addition,
ICP values provided by intraparenchymal microtrans-
ducers may depend on the site of placement [20].
When placed in one hemisphere they may not accur-
ately reflect the overall brain pressure if contusions
build up secondarily in the other hemisphere. In these
circumstances, the CM method based on the equilibra-
tion between intralabyrinthine and cerebrospinal fluid
pressures may provide complementary information on
global brain pressure after initial calibration.
Clinical targets of CM monitoring
The patients in this study were selected because the gold
standard of invasive ICP monitoring was required to
assess the CM technique. They do not constitute the
realistic target population for noninvasive ICP monitor-
ing. The present preliminary results suggest a potential
interest for the CM technique to be used whenever inva-
sive monitoring of ICP is unavailable or contraindicated,
keeping in mind the two limitations of CM, i.e., the need
for calibration to access absolute ICP and the risk of
false negatives due to the imperfect sensitivity.
With a strategy based upon the detection of an increase
in ICP of 7.5 mmHg, the same order of magnitude as the
standard deviation of the error of the best noninvasive
absolute methods published so far, CM monitoring would
spot significant ICP trends in patients starting from a clin-
ically satisfactory status, suggesting a likely normal initial
ICP. At the scene of an accident, particularly in a remote
area far from acute-care hospitals, a noninvasive method
of detecting an increase in ICP could be crucial in patients
initially categorized as having “mild brain injury” before
the onset of consciousness disorders. Mild traumatic
brain injuries are usually managed in a general hospital
if early computed tomography is normal. A significant
change in CM could signal the formation of an intra-
cranial hematoma and, together with the clinical
methods currently in use, help assess whether transfer
to a neurosurgical center is appropriate.
Management of cerebrovascular accidents provides
similar indications. In patients with ambiguous clinical
assessment, our method could contribute to early
detection of brain edema when ICP starts increasing.
Patients under the influence of alcohol or treated with
platelet anti-aggregants or anticoagulants require spe-
cial attention because they are susceptible to worsening
and difficult to monitor clinically. In these cases, non-
invasive monitoring of ICP could help decide whether
transfer to an NICU is required. Other indications
include the pediatric population whose lack of compli-
ance might make medical surveillance difficult, and the
follow up of patients referred to emergency wards for se-
vere headache on suspicion of intracranial hyperpressure,
when invasive methods cannot be performed. In addition
to primarily being used for screening in departments with-
out the possibility of invasive monitoring, CM may serve
as an outpatient tool in patients with long-lasting ICP
problems, after initial calibration by an invasive ICP
measurement.
Conclusions
In conclusion, the portability and cost-effectiveness of the
CM method, usable by paramedics in emergency vehicles
or in patients’ homes, makes it promising for use in pa-
tients who cannot currently benefit from ICP monitoring.
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